Open AccessNon-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray
Author(s) -
Saurabh Rajpal,
Liam A. Morris,
Nuri İlker Akkuş
Publication year - 2014
Publication title -
revista portuguesa de cardiologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.266
H-Index - 26
eISSN - 2174-2030
pISSN - 0870-2551
DOI - 10.1016/j.repc.2013.07.011
Subject(s) - oxymetazoline , medicine , anesthesia , agonist , nasal spray , myocardial infarction , nasal decongestant , chest pain , cardiology , pharmacology , nasal administration , receptor
Oxymetazoline is an alpha-1 adrenergic receptor agonist that is commonly used for nasal decongestion and is readily available without a prescription. We report the case of a 64-year-old woman who developed prolonged chest pain associated with elevation of cardiac biomarkers after using oxymetazoline.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom